Diagnostics: Mycology

Saturday, October 6, 2018: 12:30 PM-1:45 PM

Room: S Poster Hall

Tracks: Pediatric ID, Epidemiology and Infection Control, Adult ID

Presentations:

2032

Predictors of 6-week mortality in patients with positive bronchoalveolar lavage (BAL) galactomannan (GM).
Zoe Weiss, MD; Nour Ismail, MD; Audrey Le, MD; David W. Kubiak, PharmD, BCPS {AQ ID}; Dimitrios Farmakiotis, MD, FACP; Sophia Koo, MD, FIDSA

Posters

BALGMposterZoeFinal.pdf (1.1 MB)

2033

Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship (DS) directed toward specific intensive care unit (ICU) patients (pts) at-risk for sepsis due to invasive candidiasis (IC)
Ryan K. Shields, PharmD; Cornelius J. Clancy, M.D.; Rachel V. Marini, PharmD; Lara Groetzinger, PharmD; Ryan Rivosecchi, PharmD; Bonnie Falcione, PharmD, BCPS AQ-ID; Anthony Pasculle, ScD; M. Hong Nguyen, MD

2034

Natural Antibodies Affects the Formation of Titan Cells in Cryptococcus neoformans in vitro
Nuria Trevijano Contador, PhD Biology; Liise-Anne Pirofski, MD, FIDSA

2035

Detection of Blastomyces dermatitidis Antigen in Urine Using a Novel Quantitative Enzyme-linked Immunosorbent Assay
Dane Granger, BSc

Posters

Blasto_UAg_Poster_IDWeek2018.pdf (515.8 kB)

2036

Plasma (1→3)-β-D-Glucan Levels correlate with Neurocognitive Functioning in HIV infected Adults
Martin Hoenigl, MD; Scott Letendre, MD; Malcolm Finkelman, MD; Sara Gianella, MD

Posters

IDSA BDG Poster final.pdf (593.2 kB)

2037

Utilization of the T2 Magnetic Resonance in the Early Detection of Invasive Candidiasis
Sonal Patel, PharmD, BCPS; David Behrman, MD (2021); Andrew Chao, MD; Allison McMullen, PhD; Jose Vazquez, MD, FACP, FIDSA; Arni Sr Srinivasa Rao, PhD

Posters

Utilization of the T2 Magnetic Resonance in the Early Detection of Invasive Candidiasis (IDWeek 2018).pdf (806.8 kB)

2038

Invasive Mucormycosis Management: Mucorales PCR Provides Important, Novel Diagnostic Information
Kyle Wilgers, BS; Joel Waddell, DO; Aaron Tyler, BS; Michelle Altrich, PhD; Allyson Hays, MD; Steve Kleiboeker, PhD; Dwight Yin, MD, MPH; Mark Wissel, PhD

Posters

MM 0839 REV0 0918 IDWeek 2018 Mucor Abstract Poster FINAL APPROVED.pdf (90.6 kB)

2039

New York State 2016-2018: Progression from Candida auris Colonization to Bloodstream Infection
Karen Southwick, MD, MSc; Eleanor H. Adams, MD, MPH; Jane Greenko, RN, MPH, CIC; Belinda Ostrowsky, MD, MPH; Rafael Fernandez, MPH; Rutvik Patel, MSW; Monica Quinn, RN, MS, CIC; Snigdha Vallabhaneni, MD, MPH; Ronald Jean Denis, BS; Richard Erazo, BS; Sudha Chaturvedi, PhD; Valerie B. Haley, PhD; Lynn Leach, MS; Yan Chun Zhu, MS; Rosalie Giardina, BS; Emily C. Lutterloh, MD, MPH; Debra S. Blog, MD, MPH

2040

Clinical application of Aspergillus lateral flow device (AspLFD) in bronchoalveolar lavage (BAL) fluid of patients (pt) with classic risk factors for invasive pulmonary aspergillosis (IPA)
Kathleen A. Linder, MD; Shiwei Zhou, MD; Carol A. Kauffman, MD; Marisa H. Miceli, MD

Posters

LFD poster FINAL.pdf (1.3 MB)

2041

Impact of T2 Candida Panel on Species Specific Anti-fungal De-escalation
Zohra Chaudhry, MD; Amit Vahia, M.D., M.P.H.; Sally Askar, MPH; Noman Hussain, MD; Mujtaba Hameed, BS*; George Alangaden, MD, FIDSA

Posters

T2 ID week final.pdf (3.6 MB)

2042

Clinical application of AspID PCR alone and in combination with Aspergillus lateral flow device (AspLFD) in bronchoalveolar lavage (BAL) fluid of patients (pt) with classic risk factors for invasive pulmonary aspergillosis (IPA)
Kathleen A. Linder, MD; Melanie Flaherty, BA; Shiwei Zhou, MD; Jose A. Diaz, MD; Carol A. Kauffman, MD; Marisa H. Miceli, MD

Posters

LFD+PCR poster 9.20 FINAL.pdf (862.8 kB)

2043

T2-Candida (T2MR) versus Beta-D-Glucan (BDG) for Preemptive Antifungal Stewardship in the Intensive Care Unit (ICU)
Christian Gill, PharmD; Laura Hencken, PharmD, BCCCP; Mark Mlynarek, RPh, BCPS; George Alangaden, MD, FIDSA; Linoj Samuel, PhD., D(ABMM); Rachel Kenney, PharmD; Susan L Davis, PharmD

Posters

ID Week Poster CGill Neg T2 AF stewardship 9.25.18 Final.pdf (189.5 kB)

2044

Utility of Serum Beta-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
Prakhar Vijayvargiya, MD; Zerelda Esquer Garrigos, MD; Omar Abu Saleh, MD; Mark P. Wilhelm, MD, FIDSA; Raymund R. Razonable, MD, FIDSA; M Rizwan Sohail, MD

2045

Pitfalls in the use of MALDI TOF Mass Spectrometry for the Identification of problematic yeast isolates from a historical collection.
Monica Pachar, Medical Doctor; Violeta Chavez, PhD; Jose Rodriguez, MT; John Rex, MD; Peter Pappas, MD; Audrey Wanger, PhD; Luis Ostrosky-Zeichner, MD, FIDSA, FSHEA

Posters

poster id week 2018 maldi tof_os_pachar.pdf (1.2 MB)

2046

FungiScope™ – News on the Global Emerging Fungal Infection Registry
Danila Seidel, PhD; Philipp Koehler, MD; Sibylle Mellinghoff, MD; Maria J. G. T. Vehreschild, MD; Jon Salmanton García, MSc; Hilmar Wisplinghoff, MD; Janne Vehreschild, Prof. Dr. med.; Oliver A. Cornely, MD

Posters

IDweek_FungiScope_Poster_2018-10_landscape.pdf (1.5 MB)

2047

Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
Pratibha Ramchandra Kale, MD DNB MNAMS; Vikas Khillan, MD; Shivkumar Sarin, MD DM

Posters

ID WEEK POSTER.pdf (290.3 kB)

2048

Comparison Between Endpoint and Real-Time (RT) Polymerase Chain Reaction (PCR) for the Diagnosis of Pneumocystis Pneumonia (PCP)
Shiwei Zhou, MD; Carol A. Kauffman, MD; Michael A. Bachman, MD, PhD; Marisa H. Miceli, MD

Posters

PCP_poster_Zhou.pdf (597.1 kB)

2049

Pneumocystis jiroveci Detection by Nested PCR in HIV-Infected Peruvian Patients
Jimmy Camargo, MD; Beatriz Bustamante, MD; Edgar Neyra, PhD; Theresa Ochoa, MD; Fiorela Alvarez, MD; Coralith Garcia, PhD

2050

Plasma Next-Generation Sequencing for Pathogen Detection in Pediatric Patients at Risk for Invasive Fungal Infection
Amy Armstrong, MD; Jenna Rossoff, MD; Romielle Aquino, BA; Desiree Hollemon, MSN, MPH; David Hong, MD; Sonali Chaudhury, MD; William Muller, MD, PhD

2051

Detection of Candida auris Among Previously Unidentified Yeasts Isolated from Ear Discharge Specimens in Japan
Shigekazu Iguchi, MD, PhD; Ryo Mizushima, MD; Keisuke Kamada, MD; Yasutomo Itakura, MD; Atsushi Yoshida, MD, PhD, DTM&H; Yutaka Uzawa, M.T; Yuko Arai, MT; Takashi Umeyama, PhD; Yoshitsugu Miyazaki, MD, PhD; Tsuyoshi Sekizuka, PhD; Makoto Kuroda, PhD; Kouichi Makimura, MD, PhD; Ken Kikuchi, MD, PhD

2052

Performance of the Biofire Filmarray Meningitis/Encephalitis Panel in Cryptococcal Meningitis Diagnosis
Morgan Walker, M.D.; Jeffery Sheets, MT; Diana Hamer, PhD; Catherine O'Neal, MD

Posters

IDweek Crypto Final PRINT.pdf (544.5 kB)

2053

Tissue-based molecular diagnostics: A sensitive and specific way for the identification of invasive fungal infections in the combat-related setting
Anuradha Ganesan, MD, MPH; Faraz Shaikh, MS; Philip Peterson, MD; William P. Bradley, MS; Brian Johnson, BS; Denise Bennett, MS; Leigh Carson, MS; Teresa Merritt, BS; Kevin S. Akers, MD, FIDSA; Justin Wells, MD; Ralf Bialek, MD; David R. Tribble, MD, DrPH; Brian Wickes, PhD

Posters

ID Week IFI poster_fnl.pdf (345.0 kB)

2054

Physician Responses to Positive Rapid Diagnostic Tests for Candida Fungemia in the Absence of Concomitant Positive Blood Cultures
Tanaya Bhowmick, MD; Laura Jones, BS; Thomas Kirn, MD, PhD; Navaneeth Narayanan, PharmD, BCPS; Melvin Weinstein, MD

Posters

T2 case series poster IDweek 2018 9.25.18.pdf (762.7 kB)

2055

Utility of Aspergillus Galactomannan Assay in Allogeneic Stem Cell Transplant Recipients
Sabeen Dagher, PharmD; Katherine Medley, PharmD; Nina Haste, PharmD, PhD; Randy Taplitz, MD

Posters

Taplitz-etal-IDWeek-Posterfinal2055-%2820181003%29 (2).pdf (2.5 MB)

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Poster Abstract Session

<< Previous Session | Next Session >>

Navigation

Browse by Day:

Browse by Track: